Clinical Trial Update: Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating laboratory-treated T cells in relapsed hematologic malignancies after donor stem cell transplantation; trial terminated with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2022-06-23